Wellington Management Group LLP Decreases Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Wellington Management Group LLP lessened its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 85.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,319,915 shares of the company's stock after selling 7,713,728 shares during the period. Wellington Management Group LLP owned 0.19% of Avantor worth $30,134,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in AVTR. Norges Bank bought a new stake in Avantor in the 4th quarter worth $156,455,000. Point72 Asset Management L.P. bought a new stake in shares of Avantor during the 4th quarter valued at about $93,433,000. Avidity Partners Management LP bought a new stake in shares of Avantor during the 4th quarter valued at about $48,442,000. Westfield Capital Management Co. LP boosted its stake in shares of Avantor by 27.6% during the 4th quarter. Westfield Capital Management Co. LP now owns 5,418,922 shares of the company's stock valued at $123,714,000 after purchasing an additional 1,171,976 shares in the last quarter. Finally, Public Sector Pension Investment Board boosted its stake in shares of Avantor by 65.6% during the 3rd quarter. Public Sector Pension Investment Board now owns 2,538,995 shares of the company's stock valued at $53,522,000 after purchasing an additional 1,005,480 shares in the last quarter. Institutional investors own 95.08% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Avantor from $23.00 to $25.00 and gave the company a "hold" rating in a research note on Thursday, April 18th. Evercore ISI lifted their target price on shares of Avantor from $26.00 to $28.00 and gave the company an "outperform" rating in a research note on Thursday, April 4th. Barclays lifted their target price on shares of Avantor from $27.00 to $30.00 and gave the company an "overweight" rating in a research note on Wednesday, April 10th. Finally, Robert W. Baird lowered their price target on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research report on Monday, April 29th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat.com, Avantor presently has an average rating of "Moderate Buy" and a consensus target price of $26.71.

Avantor Stock Down 1.9 %

Avantor stock traded down $0.43 during trading hours on Tuesday, hitting $22.07. The stock had a trading volume of 4,991,319 shares, compared to its average volume of 5,781,762. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.94. The stock has a market capitalization of $14.99 billion, a P/E ratio of 56.59, a price-to-earnings-growth ratio of 2.25 and a beta of 1.35. Avantor, Inc. has a 12-month low of $16.63 and a 12-month high of $26.16. The stock's 50-day moving average price is $23.90 and its 200-day moving average price is $23.82.

Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.02. The business had revenue of $1.68 billion during the quarter, compared to analysts' expectations of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The business's revenue for the quarter was down 5.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.29 earnings per share. Equities research analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.